Isabelle Riviere

Title: The Innovations of Isabelle Riviere

Introduction

Isabelle Riviere is a prominent inventor based in Boston, MA. She has made significant contributions to the field of gene therapy, particularly through her innovative work with retroviral vectors. Her research has the potential to impact the treatment of various diseases, showcasing her dedication to advancing medical science.

Latest Patents

Isabelle Riviere holds a patent for "Retroviral gene therapy vectors and therapeutic methods based thereon." This patent describes retroviral vectors that include an insertion site for genes of interest, capable of expressing high levels of proteins derived from these genes in a variety of transfected cell types. Additionally, her vectors are designed to lack a selectable marker, making them suitable for human gene therapy without the co-expression of marker products, such as antibiotics. This innovation is particularly beneficial for use in specific packaging cell lines.

Career Highlights

Throughout her career, Isabelle has worked with esteemed organizations such as the Whitehead Institute for Biomedical Research and Cell Genesys, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Isabelle has collaborated with notable colleagues, including Lawrence K Cohen and Brad Guild. These partnerships have further enriched her research and expanded the impact of her innovations.

Conclusion

Isabelle Riviere's work in retroviral gene therapy represents a significant advancement in medical technology. Her innovative approaches and dedication to research continue to pave the way for future developments in gene therapy.